Treace Medical Concepts Stock (NASDAQ:TMCI)
Previous Close
$6.76
52W Range
$3.92 - $11.76
50D Avg
$8.72
200D Avg
$7.33
Market Cap
$416.33M
Avg Vol (3M)
$422.11K
Beta
0.78
Div Yield
-
TMCI Company Profile
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
TMCI Performance
Peer Comparison
Ticker | Company |
---|---|
ESTA | Establishment Labs Holdings Inc. |
AXGN | AxoGen, Inc. |
LUNG | Pulmonx Corporation |
KIDS | OrthoPediatrics Corp. |
CNMD | CONMED Corporation |
FNA | Paragon 28, Inc. |
SGHT | Sight Sciences, Inc. |
TCMD | Tactile Systems Technology, Inc. |
RXST | RxSight, Inc. |
NPCE | NeuroPace, Inc. |
LIVN | LivaNova PLC |
IRMD | IRadimed Corporation |
SRDX | Surmodics, Inc. |
ITGR | Integer Holdings Corporation |
OFIX | Orthofix Medical Inc. |